Positive Clinical Data Evaluating The Micrus Endovascular Cerecyte Microcoil Published In Peer-Reviewed Journals (Medical News Today)

Micrus Endovascular Corporation (Nasdaq: MEND) today announced that positive data from two clinical studies evaluating the use of the Micrus Endovascular Cerecyte bioactive microcoil in the treatment of cerebral aneurysms have been published in peer-reviewed scientific journals. Click here for more…

No comments yet. Be the first.

Leave a reply

You must be logged in to post a comment.